Картка документу
ЗАСТОСУВАННЯ ПОХІДНИХ АЛКІЛФОСФОЛІПІДІВ ЗІ ЗНИЖЕНОЮ ЦИТОТОКСИЧНІСТЮ
Бібліографія
Патент України (на 20 р.)
(51)
МПК
A61K 31/661 (2006.01)
A61K 31/675 (2006.01)
A61K 31/683 (2006.01)
A61K 31/685 (2006.01)
A61P 31/00 (2006.01)
A61P 31/04 (2006.01)
A61K 31/661 (2006.01)
A61K 31/675 (2006.01)
A61K 31/683 (2006.01)
A61K 31/685 (2006.01)
A61P 31/00 (2006.01)
A61P 31/04 (2006.01)
(11)
99434
(22)
19.12.2006
(24)
27.08.2012
(21)
a200808785
(31)
5027823.3
(32)
20.12.2005
(33)
EP
(31)
60/751,438
(32)
19.12.2005
(33)
US
(41)
10.09.2008, бюл. № 17
(46)
27.08.2012, бюл. № 16
(56)
SUNDAR S. ET AL.: "Trial of oral miltefosine for visceral leishmaniasis" // LANCET, 1998, vol. 352, no. 9143, pages 1821-1823
SGAMBATTI DE ANDRADE ET AL.: "Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection" // LANCET 1996, vol. 348, no. 9039, pages 1407-1413
KOUFAKI M ET AL.: "Alkyl and alkoxyethyl antineoplastic phospholipids." // JOURNAL OF MEDICINAL CHEMISTRY 1996, vol. 39, no. 13, pages 2609-2614
AVLONITIS N. ET AL.: "Antileishmanial ring-substituted ether phospholipids" // JOURNAL OF MEDICINAL CHEMISTRY 2003, vol. 46, no. 5, pages 755-767
STEKAR JURIJ ET AL.: "SYNTHESIS, ANTITUMOR ACTIVITY, AND TOLERABILITY OF PHOSPHOLIPIDS CONTAINING NITROGEN HOMOLOGS" // ANGEWANDTE CHEMIE 1995, vol. 34, no. 2, pages 238-240
KUCERA L. S. ET AL.: "NOVEL MEMBRANE-INTERACTIVE ETHER LIPID ANALOGS THAT INHIBIT INFECTIOUS HIV-1 PRODUCTION AND INDUCE DEFECTIVE VIRUS FORMATION" // AIDS RESEARCH AND HUMAN RETROVIRUSES 1990, vol. 6, no. 4, pages 491-501
KONSTANTINOV S. M. ET AL.: "HUMAN URINARY BLADDER CARCINOMA CELL LINES RESPOND TO TREATMENT WITH ALKYLPHOSPHOCHOLINES" // CANCER LETTERS 1999, vol. 144, no. 2, pages 153-160
KONSTANTINOV, SPIRO M. ET AL.: "Alkylphosphocholines induce apoptosis in HL-60 and U-937 leukemic cells" // CANCER CHEMOTHERAPY AND PHARMACOLOGY 1998, vol.41, no.3, 210-216
PAPAZAFIRI PANAGIOTA ET AL.: "Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives" // CANCER CHEMOTHERAPY AND PHARMACOLOGY 2005, vol. 56, no. 3, pages 261-270
STEKAR JURIJ ET AL.: "Antineoplastic activity and tolerability of a novel heterocyclic alkylphospholipid, D-20133" // CANCER CHEMOTHERAPY AND PHARMACOLOGY 1993, vol. 32, no. 6, pages 437-444
ENGEL, J. ET AL.: "Perifosine: oncolytic, ether phospholipid" // DRUGS OF THE FUTURE 2000, vol.25, no.12, 1257-1260
CRUL M. ET AL.: "Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours." // EUROPEAN JOURNAL OF CANCER 2002, vol. 38, no. 12, pages 1615-1621
HILGARD P. ET AL.: "D-21266, a new heterocyclic alkylphospholipid with antitumour activity." // EUROPEAN JOURNAL OF CANCER 1997, vol. 33, no. 3, pages 442-446
KONSTANTINOV S. M. ET AL.: "Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies" // ACTA TROPICA 1997, vol.64, no. 3-4, pages 145-154
KANETANI, FUJIO ET AL.: "Synthesis, and physicochemical and antimicrobial properties of alkylphosphorylcholines" // NIPPON KAGAKU KAISHI 1984, (9), pages 1452-8
COOPER, DAVID L. ET AL.: "Molecular similarity of anti-HIV phospholipids" // JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 1993, vol.115, no.26, pages 12615-16
CROFT SIMON L ET AL.: "Antiprotozoal activities of phospholipid analogues." // MOLECULAR AND BIOCHEMICAL PARASITOLOGY 2003, vol. 126, no. 2, pages 165-172
DUIJSINGS DANIЕL ET AL.: "Hexadecylphosphocholine causes rapid cell death in canine mammary tumour cells." // EUROPEAN JOURNAL OF PHARMACOLOGY 2004, vol. 502, no. 3, pages 185-193
Navin K. Verma and Chinmoy S. Dey "Possible Mechanism of Miltefosine-Mediated Death of
Leishmania donovani" ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, Vol. 48, No. 8, p. 3010–3015
KARIN SEIFERT et al.: "Effects of Miltefosine and Other Alkylphosphocholines on
Human Intestinal Parasite Entamoeba histolytica" ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2001,Vol. 45, No. 5, p. 1505–1510
Julia Walochnik et al "Cytotoxic Activities of Alkylphosphocholines against Clinical Isolates
of Acanthamoeba spp." ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2002, Vol. 46, No. 3, p. 695–701
Blaha C. et al.: "In vitro activity of hexadecylphosphocholine (miltefosine)
against metronidazole-resistant and -susceptible strains of
Trichomonas vaginalis" Journal of Antimicrobial Chemotherapy (2006) 57, 273–278
WO 03/080071 A1; 02.102003
WO 03/061669 A1; 31.07.2003
WO 03/028736 A2; 10.04.2003
EP 0 534 445 A1; 31.03.1993
EP 0 579 939 A1; 26.01.1994
WO 2004/012744 A1; 12.02.2004
US 2003/216355 A1; 20.11.2003
US 2004/242543 A1; 02.12.2004
WO 00/33917 A1;15.06.2000
DE 39 42 933 A1; 27.06.1991
DE 198 35 611 A1; 10.02.2000
WO 2004/041167 A2; 21.05.2004
WO 2006/122716 A1; 23.11.2006
EP 0 507 337 A2; 07.10.1992
EP 0 108 565 A2; 16.05.1984
EP 0 521 353 A1; 07.01.1993
(85)
19.07.2008
(86)
PCT/EP2006/069873, 19.12.2006
(71)
АЕТЕРНА ЦЕНТАРІС ГМБХ 
АЭТЕРНА ЦЕНТАРИС ГМБХ
AETERNA ZENTARIS GMBH
(72)
Перріссу Даніель ; Пітрас Матіас ; ЕНГЕЛЬ Юрген
; Пітрас Матіас ; ЕНГЕЛЬ Юрген Перриссу Даниэль ; Питрас Матиас ; Энгель Юрген
; Питрас Матиас ; Энгель Юрген Perrissoud Daniel ; Pietras, Mathias ; ENGEL JUERGEN ; Engel. Jurgen
; Pietras, Mathias ; ENGEL JUERGEN ; Engel. Jurgen (73)
АЕТЕРНА ЦЕНТАРІС ГМБХ
АЭТЕРНА ЦЕНТАРИС ГМБХ
AETERNA ZENTARIS GMBH
(74)
Дубинський Михайло Ілліч
(98)
Дубинський Михайло Iллiч
а/с 295, м. Київ, 03150
а/с 295, м. Київ, 03150